Marinus Pharmaceuticals I... (MRNS)
NASDAQ: MRNS
· Real-Time Price · USD
0.55
0.00 (0.00%)
At close: Feb 10, 2025, 3:59 PM
Marinus Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.23M | -35.83M | -38.67M | -41.77M | -32.97M | -31.93M | -34.73M | -34.31M | 73.29M | -39.43M | -19.36M | -28.3M | -19.51M | -23.82M | -27.14M |
Depreciation & Amortization | -884K | 140K | 131K | 125K | 142K | 127K | 157K | 82K | 158K | 93K | 85K | 93K | 91K | 86K | 85K |
Stock-Based Compensation | 4.83M | 4.92M | 5.19M | 3.92M | 4.01M | 3.89M | 3.74M | 3.8M | 3.9M | 3.82M | 3.38M | 3M | 2.84M | 2.99M | 5.04M |
Other Working Capital | 2.53M | 1.19M | -3.31M | 4.27M | 2.19M | 2.18M | 544K | 7.19M | 491K | 521K | -13.19M | -3.16M | 21.66M | -2.48M | 366K |
Other Non-Cash Items | 2.3M | 2.59M | 9.18M | -704K | 1.79M | 1.82M | 1.49M | 2.24M | 144K | 379K | 2.21M | 318K | 322K | 270K | 155K |
Deferred Income Tax | n/a | n/a | n/a | 1.49M | -327K | -441K | n/a | n/a | n/a | n/a | n/a | -687K | n/a | n/a | n/a |
Change in Working Capital | -1.47M | -2.66M | -5.58M | 9.94M | 2.19M | 2.18M | -12.14M | 6.28M | 135K | 1.47M | -13.97M | 3.83M | 21.66M | -2.48M | 5.69M |
Operating Cash Flow | -19.45M | -30.84M | -37.46M | -26.99M | -25.17M | -24.36M | -41.48M | -21.91M | -29.64M | -33.67M | -27.66M | -21.75M | 5.4M | -22.95M | -16.18M |
Capital Expenditures | -1.11M | -38K | n/a | -34K | -85K | n/a | n/a | -92K | -1.26M | -335K | -86K | -721K | -872K | -864K | -432K |
Cash Acquisitions | n/a | n/a | n/a | -9K | 5K | 4K | n/a | 171K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | 5K | -5K | n/a | -51.99M | -171K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 9M | 20.89M | 6.5M | 12M | 5M | n/a | -107.38M | 107.38M | n/a | n/a | n/a | n/a | n/a | 1.47M |
Other Investing Acitivies | n/a | n/a | 20.89M | 6.5M | 5K | 5M | -51.99M | 107.55M | 107.38M | n/a | n/a | -1.79M | n/a | n/a | 1.47M |
Investing Cash Flow | -1.11M | 8.96M | 20.89M | 6.47M | 11.92M | 5M | -51.99M | 79K | 106.11M | -335K | -86K | -721K | -872K | -864K | 1.04M |
Debt Repayment | -1.93M | n/a | n/a | 737K | n/a | n/a | n/a | 29.63M | -562K | n/a | 29.4M | n/a | 27.98M | 12.28M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -17.7M | 257K | n/a | 25.9M | 237K | -174K | 64.51M | 16K | 14K | 1.73M | 297K | 101K | n/a | 96K |
Financial Cash Flow | -1.93M | -17.7M | 257K | 661K | 25.9M | 237K | -174K | 94.14M | -546K | 14K | 31.13M | 297K | 28.08M | 12.84M | 96K |
Net Cash Flow | -22.49M | -39.58M | -16.32M | -19.86M | 12.65M | -19.12M | -93.65M | 72.3M | 75.92M | -33.99M | 3.39M | -22.17M | 32.61M | -10.98M | -15.04M |
Free Cash Flow | -20.57M | -30.88M | -37.46M | -27.03M | -25.26M | -24.36M | -41.48M | -22.01M | -30.91M | -34.01M | -27.74M | -22.47M | 4.53M | -23.82M | -16.61M |